🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Research led by Dr. Lajos Pusztai YaleBreastCancer finds pts with stage I/II #breastcancers have excellent prognosis, yet account for >60% of breast cancer-specific death because of the high number of patients who present with #earlystage disease. The importance of adequate treatment

Dr. Alejandro Rios Hoyo Alejandro Rios and Adriana Kahn, MD present on the “Genomic Landscape in Advanced Breast Cancer Across Different Genomic Ancestries” at #SABCS24 SABCS YaleBreastCancer Smilow Cancer Hospital #bcsm

.Maryam Lustberg MD, MPH, FASCO presents a summary of survivorship poster presentations #SABCS24 “Health promotion should be done in collaboration with our patients and should not create extra stress for them.” YaleBreastCancer SABCS Smilow Cancer Hospital Yale School of Medicine #bcsm

The final webinar in our Post-San Antonio Breast Cancer Symposium (#SABCS) will discuss New Treatment Options for #MetastaticBreastCancer. Join host Maryam Lustberg MD, MPH, FASCO and Adriana Kahn, MD tonight at 6pm. RSVP: bit.ly/40ffiVM #bcsm Smilow Cancer Hospital Yale School of Medicine Yale New Haven Hosp YaleBreastCancer

Dr. Flaherty has supported the next generation of cancer investigators with his commitment to mentorship, and he has inspired them with his groundbreaking translational discoveries. The AACR will benefit from his visionary leadership when he takes the gavel in 2026.

We are looking for a junior clinical investigator to join our myeloma program within division of heme malignancies at Yale Cancer Center YaleHematology Yale University if you want to apply or recommend someone plz reach out to me or to our myeloma program leader Natalia Neparidze plz spread word

This hall will be the epicenter of the cancer research community Sunday morning when the #AACR25 Opening Ceremony and Opening Plenary Session begin. Margaret Foti, PhD, MD (hc) Marge Foti and I look forward to seeing everyone there.

Proud to see AACR led by AACR President Patricia M. LoRusso and mentor Dr. LoRusso committed to move #ClinicalTrials and #Cancer therapeutics forward leveraging collaborations between basic science, clinical research and patients and advocates in the US and globally! #AACR25 Smilow Cancer Hospital Yale Cancer Center

Cancer journalism worldwide awarded at angel chagolla and particularly proud of the Brazilian team revealing challenges faced by the Amazon women when diagnosed with cancer #AACR25 🇧🇷

What a stellar pair of mentor and mentee! Outstanding drug developers AACR President Patricia M. LoRusso Dr. LoRusso awarding her prior fellowship director and current FDA Oncology Rick Pazdur Director of the Oncology Center of Excellence for his trailblazing career! #AACR25 AACR Yale Cancer Center

At the #AACR25 President's Dinner last night, I had the opportunity to thank our distinguished AACR President Patricia M. LoRusso, Pat LoRusso, for her outstanding service to the AACR over the past year. Congratulations, Pat, on a spectacular term as AACR President.

“When research funding is cut, #patients pay the price and a generation of discoveries is lost. We must protect the independence and integrity of science and remain focused on the #patients. This is not someone else’s problem, but ours” by AACR President Patricia M. LoRusso AACR #AACR25 Yale Cancer Center

“Fight for your science. Fight for what is best for the people. Do not let this moment slow you down. We cannot give up on helping people who need us.” Dr. Monica Bertagnolli, MD, former #NIH/#NCI Director at #AACR25 AACR

“The NIH plays an economical role in generating jobs for scientists, lab suppliers, shipping, construction and pharmaceutical companies. An initial 1 million dollars’ in investment can generate 650 million dollars in economical growth on top of saving lives” #AACR25 E. John Wherry

Meaningful data on PARP inhibitor plus immune checkpoint inhibitor in patients with mutated BRCA 1/2, but also non-BRCA but other HRR mutations (eg PALB2, CHEK2, ATM, BRIP1, CDK12) or HRD-positive disease on KEYLYNK-007 presented by Dr. Tim Yap @#AACR25 AACR

An emotionally outstanding presentation on AACR President Patricia M. LoRusso Dr. LoRusso’s vision for the future of Oncology and her appreciation for those who encouraged and believed in her, and how she pays this back by leading and inspiring so many more! #AACR25 AACR Yale Cancer Center